Microvascular impairment associated with percutaneous coronary revascularization: The quest for protective microcirculatory strategies

Affiliations

¹ Unit of Cardiovascular Science, Department of Medicine, Campus Bio-Medico University, Rome, Italy.
² Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy. Electronic address: barba22@hotmail.com.

Comment

Fabio Mangiacapra et al. Int J Cardiol. 2020.

. 2020 Jun 1:308:9.

doi: 10.1016/j.ijcard.2020.03.029.

¹ Unit of Cardiovascular Science, Department of Medicine, Campus Bio-Medico University, Rome, Italy.
² Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy. Electronic address: barba22@hotmail.com.

No abstract available

Comment on

Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention.
Mangiacapra F, Bressi E, Di Gioia G, Pellicano M, Di Serafino L, Peace AJ, Bartunek J, Morisco C, Wijns W, De Bruyne B, Barbato E. Mangiacapra F, et al. Int J Cardiol. 2020 May 1;306:42-46. doi: 10.1016/j.ijcard.2019.12.042. Epub 2019 Dec 24. Int J Cardiol. 2020. PMID: 31926642
Nicorandil, a promising drug for the prevention of percutaneous coronary artery intervention-related myocardial injury and infarction in patients with stable coronary artery disease.
Zhang Y, Zhu W, Ding C, Chen M, Su X, Dai W, Huang X. Zhang Y, et al. Int J Cardiol. 2020 Jun 1;308:10. doi: 10.1016/j.ijcard.2020.02.046. Int J Cardiol. 2020. PMID: 32334803 No abstract available.